pCas9D10A_GFP Citations (22)
Originally described in: Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs.Ding Q, Regan SN, Xia Y, Oostrom LA, Cowan CA, Musunuru K Cell Stem Cell. 2013 Apr 4;12(4):393-4. doi: 10.1016/j.stem.2013.03.006. PubMed Journal
Articles Citing pCas9D10A_GFP
| Articles |
|---|
| Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. Ghezraoui H, Piganeau M, Renouf B, Renaud JB, Sallmyr A, Ruis B, Oh S, Tomkinson AE, Hendrickson EA, Giovannangeli C, Jasin M, Brunet E. Mol Cell. 2014 Sep 18;55(6):829-42. doi: 10.1016/j.molcel.2014.08.002. Epub 2014 Sep 4. PubMed |
| Creating cancer translocations in human cells using Cas9 DSBs and nCas9 paired nicks. Renouf B, Piganeau M, Ghezraoui H, Jasin M, Brunet E. Methods Enzymol. 2014;546:251-71. doi: 10.1016/B978-0-12-801185-0.00012-X. PubMed |
Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9.
Chen Y, Cao J, Xiong M, Petersen AJ, Dong Y, Tao Y, Huang CT, Du Z, Zhang SC.
Cell Stem Cell. 2015 Jul 1. pii: S1934-5909(15)00261-1. doi: 10.1016/j.stem.2015.06.001.
PubMed
Associated Plasmids |
| CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting. Courtney DG, Moore JE, Atkinson SD, Maurizi E, Allen EH, Pedrioli DM, McLean WH, Nesbit MA, Moore CB. Gene Ther. 2016 Jan;23(1):108-12. doi: 10.1038/gt.2015.82. Epub 2015 Aug 20. PubMed |
| Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-20. Shetty DK, Inamdar MS. Stem Cell Res. 2016 Mar;16(2):207-9. doi: 10.1016/j.scr.2015.12.041. Epub 2016 Jan 6. PubMed |
| Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-39. Shetty DK, Inamdar MS. Stem Cell Res. 2016 Mar;16(2):308-10. doi: 10.1016/j.scr.2015.12.037. Epub 2016 Jan 5. PubMed |
| Efficient CRISPR/Cas9-assisted gene targeting enables rapid and precise genetic manipulation of mammalian neural stem cells. Bressan RB, Dewari PS, Kalantzaki M, Gangoso E, Matjusaitis M, Garcia-Diaz C, Blin C, Grant V, Bulstrode H, Gogolok S, Skarnes WC, Pollard SM. Development. 2017 Feb 15;144(4):635-648. doi: 10.1242/dev.140855. Epub 2017 Jan 17. PubMed |
| Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function. Lai FP, Lau ST, Wong JK, Gui H, Wang RX, Zhou T, Lai WH, Tse HF, Tam PK, Garcia-Barcelo MM, Ngan ES. Gastroenterology. 2017 Jul;153(1):139-153.e8. doi: 10.1053/j.gastro.2017.03.014. Epub 2017 Mar 23. PubMed |
| The LDB1 Complex Co-opts CTCF for Erythroid Lineage-Specific Long-Range Enhancer Interactions. Lee J, Krivega I, Dale RK, Dean A. Cell Rep. 2017 Jun 20;19(12):2490-2502. doi: 10.1016/j.celrep.2017.05.072. PubMed |
| Mutations in RAB39B in individuals with intellectual disability, autism spectrum disorder, and macrocephaly. Woodbury-Smith M, Deneault E, Yuen RKC, Walker S, Zarrei M, Pellecchia G, Howe JL, Hoang N, Uddin M, Marshall CR, Chrysler C, Thompson A, Szatmari P, Scherer SW. Mol Autism. 2017 Nov 9;8:59. doi: 10.1186/s13229-017-0175-3. eCollection 2017. PubMed |
| Metabolic and Organelle Morphology Defects in Mice and Human Patients Define Spinocerebellar Ataxia Type 7 as a Mitochondrial Disease. Ward JM, Stoyas CA, Switonski PM, Ichou F, Fan W, Collins B, Wall CE, Adanyeguh I, Niu C, Sopher BL, Kinoshita C, Morrison RS, Durr A, Muotri AR, Evans RM, Mochel F, La Spada AR. Cell Rep. 2019 Jan 29;26(5):1189-1202.e6. doi: 10.1016/j.celrep.2019.01.028. PubMed |
| SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons. Zaslavsky K, Zhang WB, McCready FP, Rodrigues DC, Deneault E, Loo C, Zhao M, Ross PJ, El Hajjar J, Romm A, Thompson T, Piekna A, Wei W, Wang Z, Khattak S, Mufteev M, Pasceri P, Scherer SW, Salter MW, Ellis J. Nat Neurosci. 2019 Apr;22(4):556-564. doi: 10.1038/s41593-019-0365-8. Epub 2019 Mar 25. PubMed |
| Altered calcium dynamics and glutamate receptor properties in iPSC derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations. Bursch F, Kalmbach N, Naujock M, Staege S, Eggenschwiler R, Abo-Rady M, Japtok J, Guo W, Hensel N, Reinhardt P, Boeckers TM, Cantz T, Sterneckert J, Van Den Bosch L, Hermann A, Petri S, Wegner F. Hum Mol Genet. 2019 May 21. pii: 5492438. doi: 10.1093/hmg/ddz107. PubMed |
| Modeling Monogenic Diabetes using Human ESCs Reveals Developmental and Metabolic Deficiencies Caused by Mutations in HNF1A. Cardenas-Diaz FL, Osorio-Quintero C, Diaz-Miranda MA, Kishore S, Leavens K, Jobaliya C, Stanescu D, Ortiz-Gonzalez X, Yoon C, Chen CS, Haliyur R, Brissova M, Powers AC, French DL, Gadue P. Cell Stem Cell. 2019 Aug 1;25(2):273-289.e5. doi: 10.1016/j.stem.2019.07.007. PubMed |
Human Stem Cell-Derived Neurons Repair Circuits and Restore Neural Function.
Xiong M, Tao Y, Gao Q, Feng B, Yan W, Zhou Y, Kotsonis TA, Yuan T, You Z, Wu Z, Xi J, Haberman A, Graham J, Block J, Zhou W, Chen Y, Zhang SC.
Cell Stem Cell. 2020 Sep 16. pii: S1934-5909(20)30410-0. doi: 10.1016/j.stem.2020.08.014.
PubMed
Associated Plasmids |
| ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine. Fontana D, Mauri M, Renso R, Docci M, Crespiatico I, Rost LM, Jang M, Niro A, D'Aliberti D, Massimino L, Bertagna M, Zambrotta G, Bossi M, Citterio S, Crescenzi B, Fanelli F, Cassina V, Corti R, Salerno D, Nardo L, Chinello C, Mantegazza F, Mecucci C, Magni F, Cavaletti G, Bruheim P, Rea D, Larsen S, Gambacorti-Passerini C, Piazza R. Nat Commun. 2020 Nov 23;11(1):5938. doi: 10.1038/s41467-020-19721-w. PubMed |
| Modulation of APLNR Signaling Is Required during the Development and Maintenance of the Hematopoietic System. Jackson M, Fidanza A, Taylor AH, Rybtsov S, Axton R, Kydonaki M, Meek S, Burdon T, Medvinsky A, Forrester LM. Stem Cell Reports. 2021 Apr 13;16(4):727-740. doi: 10.1016/j.stemcr.2021.02.003. Epub 2021 Mar 4. PubMed |
| AP-2alpha Regulates S-Phase and Is a Marker for Sensitivity to PI3K Inhibitor Buparlisib in Colon Cancer. Beck AC, Cho E, White JR, Paemka L, Li T, Gu VW, Thompson DT, Koch KE, Franke C, Gosse M, Wu VT, Landers SR, Pamatmat AJ, Kulak MV, Weigel RJ. Mol Cancer Res. 2021 Jul;19(7):1156-1167. doi: 10.1158/1541-7786.MCR-20-0867. Epub 2021 Mar 22. PubMed |
| Novel vertebrate- and brain-specific driver of neuronal outgrowth. Jansen EJR, van Bakel NHM, Benedict B, Olde Loohuis NFM, Hafmans TGM, Chim SM, Xu J, Kolk SM, Martens GJM. Prog Neurobiol. 2021 Jul;202:102069. doi: 10.1016/j.pneurobio.2021.102069. Epub 2021 Apr 29. PubMed |
| Physiological Characterization and Transcriptomic Properties of GnRH Neurons Derived From Human Stem Cells. Keen KL, Petersen AJ, Figueroa AG, Fordyce BI, Shin J, Yadav R, Erdin S, Pearce RA, Talkowski ME, Bhattacharyya A, Terasawa E. Endocrinology. 2021 Sep 1;162(9). pii: 6298609. doi: 10.1210/endocr/bqab120. PubMed |
| AP-2alpha-Mediated Activation of E2F and EZH2 Drives Melanoma Metastasis. White JR, Thompson DT, Koch KE, Kiriazov BS, Beck AC, van der Heide DM, Grimm BG, Kulak MV, Weigel RJ. Cancer Res. 2021 Sep 1;81(17):4455-4470. doi: 10.1158/0008-5472.CAN-21-0772. Epub 2021 Jul 1. PubMed |
| Generation of OCIAD2 homozygous knockout (BJNhem20-OCIAD2-CRISPR-33) and heterozygous knockout (BJNhem20-OCIAD2-CRISPR-40) human embryonic stem cell lines using CRISPR-Cas9 mediated targeting. Kamat K, Inamdar MS. Stem Cell Res. 2023 Mar;67:103026. doi: 10.1016/j.scr.2023.103026. Epub 2023 Jan 9. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.